A type of arthrogryposis characterized by congenital cleft palate microcephaly craniostenosis and arthrogryposis (limitation of extension of elbows flexed adducted thumbs camptodactyly and clubfeet). Additional features include facial dysmorphism (‘myopathic’ stiff face antimongoloid slanting external ophthalmoplegia telecanthus low-set large malrotated ears open mouth mierogenia and high arched palate). Velopharyngeal insufficiency with difficulties in swallowing increased secretion of the nose and throat prominent occiput generalized muscular hypotonia with mild cyanosis and no spontaneous movements seizures torticollis areflexia intellectual disability hypertrichosis of the lower extremities and scleredema (in the first days of life; see this term) are also observed. The disease often leads to early death. Transmission is autosomal recessive. No new cases have been described since 1983.
Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview. Reference: Access aggregated data from Orphanet at Orphadata. Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version October 2024
Newly diagnosed with
Adducted thumbs-arthrogryposis syndrome, Christian type?
Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.
Advocacy Organizations
Syndromes Without A Name (SWAN) Australia
Provide information, support and advocacy to families caring for a child with an undiagnosed or rare genetic condition.
ZC4H2 Research Foundation
Our Mission: The purpose of the ZC4H2 Research Foundation is to support the development of viable therapies and standards of clinical care for the treatment of ZC4H2 Associated Rare Disorders (ZARD), and to be an information and support network for the ZARD community. We advocate through research, awareness, and support. For more information, please visit https://www.zc4h2foundation.org.
Don't see your organization here. Let us know here.
Clinical Trials
For a list of clinical trials in this disease area, please click here.